Fusion Antibodies plc (FAB.L)

GBp 6.6

(-2.94%)

Total Liabilities Summary of Fusion Antibodies plc

Fusion Antibodies plc's latest annual total liabilities in 2023 was 627 Thousand GBP , down -33.23% from previous year.
Fusion Antibodies plc's latest quarterly total liabilities in 2023 FY was 627 Thousand GBP , down -33.23% from previous quarter.
Fusion Antibodies plc reported annual total liabilities of 939 Thousand GBP in 2022, down -23.72% from previous year.
Fusion Antibodies plc reported annual total liabilities of 1.23 Million GBP in 2021, up 13.67% from previous year.
Fusion Antibodies plc reported quarterly total liabilities of 604 Thousand GBP for 2023 Q2, down 0.0% from previous quarter.
Fusion Antibodies plc reported quarterly total liabilities of 627 Thousand GBP for 2023 FY, down -33.23% from previous quarter.

Annual Total Liabilities Chart of Fusion Antibodies plc (2023 - 2012)

Historical Annual Total Liabilities of Fusion Antibodies plc (2023 - 2012)

Year	Total Liabilities	Total Liabilities Growth
2023	627 Thousand GBP	-33.23%
2022	939 Thousand GBP	-23.72%
2021	1.23 Million GBP	13.67%
2020	1.08 Million GBP	-11.81%
2019	1.22 Million GBP	38.21%
2018	888.53 Thousand GBP	40.24%
2017	633.58 Thousand GBP	40.73%
2016	450.21 Thousand GBP	9.43%
2015	411.43 Thousand GBP	104.01%
2014	201.66 Thousand GBP	-32.23%
2013	297.56 Thousand GBP	17.35%
2012	253.56 Thousand GBP	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 Q4	627 Thousand GBP	0.0%
2023 Q2	604 Thousand GBP	0.0%
2023 FY	627 Thousand GBP	-33.23%
2022 Q2	1.41 Million GBP	0.0%
2022 FY	939 Thousand GBP	-23.72%
2022 Q4	939 Thousand GBP	0.0%
2021 Q2	1.12 Million GBP	0.0%
2021 FY	1.23 Million GBP	13.67%
2021 Q4	1.23 Million GBP	0.0%
2020 FY	1.08 Million GBP	-11.81%
2020 Q4	1.08 Million GBP	0.0%
2020 Q2	936 Thousand GBP	0.0%
2019 FY	1.22 Million GBP	38.21%
2019 Q2	894 Thousand GBP	0.0%
2019 Q4	1.22 Million GBP	0.0%
2018 Q4	888.53 Thousand GBP	11.63%
2018 FY	888.53 Thousand GBP	40.24%
2018 Q3	796 Thousand GBP	32.19%
2018 Q1	556.19 Thousand GBP	-12.21%
2018 Q2	602.18 Thousand GBP	8.27%
2017 Q1	- GBP	0.0%
2017 Q4	633.58 Thousand GBP	0.0%
2017 FY	633.58 Thousand GBP	40.73%
2016 FY	450.21 Thousand GBP	9.43%
2015 FY	411.43 Thousand GBP	104.01%
2014 FY	201.66 Thousand GBP	-32.23%
2013 FY	297.56 Thousand GBP	17.35%
2012 FY	253.56 Thousand GBP	0.0%

Peer Total Liabilities Comparison of Fusion Antibodies plc

Name	Total Liabilities	Total Liabilities Difference